valodia® valodia consortium developing a knowledge- based economy with commercialisation of science...
TRANSCRIPT
ValoDia®
VALODIA Consortium
Developing a knowledge-based economy with commercialisation of science and international investors
Peter [email protected]
ValoDia®
Empirical Findings
A Knowledge-based economy implies a vibrant innovation ecosystem shared by all stakeholders
Scientific goods (knowledge, products, patents, etc.) need to meet demands from companies to contribute to the economic development of the country
Facilitating the links between business and research players, overcoming any hurdle, including from the point of view of cultural differences implies hands-on support from specialists
It is essential the parties agree on win-win agreements that will lead to long-term partnerships
When possible, it is best to create joint-ventures or joint start-ups
ValoDia®
Conceptual approach
Need to attract high level “brains” Need to facilitate the
commercialisation of scientific results to help absorption by local and foreign companies (existing and start-ups)
Importance of attracting inward investors with the quality of local R&D teams and develop joint projects
ValoDia®
R&D expenditure % of GDP
0
1
2
3
4
Série1 0,483 0,928 3,473 0,833 2,555 0,802 0,211 3,473 0,574 1,125 1,485 0,867
Rese Bulga Croat Finlan Euro Germ India Kaza Kore Polan Russi Slove Ukrai
ValoDia®
High tech Exports from Kazakhstan ($)
0
20 000 000 000
40 000 000 000
60 000 000 000
80 000 000 000100 000 000 000
120 000 000 000
140 000 000 000
160 000 000 000
180 000 000 000
ValoDia®
The commercialisation of science paradigm shift: being “demand
Driven”
N°1: Search for European companies with technological needs
N°2: Selecting only those firms that have financial capabilities to pay for a collaboration and strong willingness
N°3: Search for R&D teams that are capable, ready and willing to enter into a concrete negotiations
N°4: Helping the European and Kazakh sides becoming more and more specific
N°5: Assisting the technology due diligence, Intellectual Property Rights, cultural differences, contractual issues, business planning, marketing, etc.
N°6: Facilitating the conclusion of “Good & Fair” deals N°7: Continuously supporting the “pairs” when created
ValoDia®
Expected outputs
Attraction of inward investors to the country
Implementation of international good practices
A concrete and measurable return-on-investment based on money, number of collaborations, joint start-ups, etc.
Expected financial return, based on European and Kazakh projects ≈ 30 times the costs of commercialisation
ValoDia® 8
Activities developed in 2008/9: French-Russian G8GP Programme
Within 18 months:
12 Russo-European technology pairscreated and supportedshort term value ≈ 1,3 mln. EuroMedium term Value ≈ 35 mln. Euro
ValoDia®
French-Russian G8GP Programme
EXAMPLE 1: ARENZO
MOLECULAR DIAGNOSTICS Kit and System: A French medium sized biotechnology firm A biological Institute that develops an innovative bio-chip An international market for diagnosis in HCV Subtyping
RUO, HCV Subtyping CE, Oncogenic viruses, etc.
Creation of a Joint Venture to: Market joint products throughout the world Adapt the Russian chip to international standards and
increase its possibilities Expected results: a turn-over of ≈ 12.000.000€ Per
Annum after the development phase (2 years +)
ValoDia®
French-Russian G8GP Programme
EXAMPLE 2: HEF/HCEI
Filtered arc technology for deposition of coatings on metalsurfaces: A French company - European leader in the field of surface
engineering A research institute in Tomsk that develops the filtered arc
technology
Creation of a Joint Venture to: Produce technological blocks in Tomsk to integrate in HEF
equipment Build surface treatment machines in Tomsk Create a sales network in Russia Expected results: a turn-over ≈ 10.000.000€ Per Annum
after the development phase and establishment of the JV (3 years +)
ValoDia®
Thank you for attention!
For any questions feel free to contact Peter Lindholm